Biotech Monthly Review, Oct 2026
Sat, Nov 07
|Scan the QR code for registration link
Join us on Saturday, November 7th, 2026, 8:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month! Register Here: https://us02web.zoom.us/webinar/register/WN_zj-4tkSzQrC5y6M0q9fUWA#/registration


Time & Location
Nov 07, 2026, 8:00 PM – 10:00 PM EST
Scan the QR code for registration link
About the event
Join us on Saturday, November 7th, 2026, 8:00 PM EST for a live online webinar where we unpack the most exciting biotech breakthroughs from the past month!
Register Here: https://us02web.zoom.us/webinar/register/WN_zj-4tkSzQrC5y6M0q9fUWA#/registration 1. Rare Diseases & New Modalities:
Rare Disease Spotlight: KCNT1-Related Epilepsy.
Merck KGaA to acquire Silence Therapeutics for $1.3B.
2. Oncology & Autoimmune Diseases:
Only the lower dose of BMS admilparant succeeded in a phase 3 trial of idiopathic pulmonary fibrosis.